![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2023/04/12/2645780/37097/en/PLx-Pharma-Inc-Enters-into-a-Stalking-Horse-Asset-Purchase-Agreement-to-Sell-VAZALORE-and-Substantially-All-of-its-Assets.html
https://www.globenewswire.com/news-release/2023/04/11/2644951/37097/en/PLx-Pharma-Inc-Receives-Nasdaq-Delisting-Notice.html
https://www.globenewswire.com/news-release/2022/10/26/2541885/37097/en/PLx-Pharma-Inc-to-Report-Third-Quarter-2022-Financial-Results-on-November-11-2022-and-Provide-Business-Update.html
https://www.fiercepharma.com/marketing/plx-pharma-strikes-new-collab-baseball-legend-john-smoltz-take-its-pain-drug-vazalore
https://www.globenewswire.com/news-release/2022/07/27/2486876/37097/en/PLx-Pharma-Inc-to-Report-Second-Quarter-2022-Financial-Results-August-12-2022-and-Provide-Business-Update.html
https://www.globenewswire.com/news-release/2022/06/01/2454288/37097/en/PLx-Pharma-Inc-to-Present-at-JMP-Securities-2022-Life-Sciences-Conference-on-June-15-2022.html
https://www.globenewswire.com/news-release/2022/05/20/2447672/37097/en/PLx-Pharma-Inc-Showcases-VAZALORE-at-The-Annual-Meeting-of-The-Society-for-Cardiovascular-Angiography-and-Interventions.html
https://www.globenewswire.com/news-release/2022/05/13/2442870/37097/en/PLx-Pharma-Inc-Reports-First-Quarter-2022-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2022/04/22/2427230/37097/en/PLx-Pharma-Inc-to-Discuss-2022-First-Quarter-Financial-Results-on-May-13-2022-Conference-Call-and-Provide-Business-Update.html
https://www.globenewswire.com/news-release/2022/03/11/2401719/37097/en/PLx-Pharma-Inc-Reports-Fourth-Quarter-and-Full-Year-2021-Results-and-Provides-Business-Update.html